(Q84263115)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Understanding the efficacy variables of an HIV vaccine trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

José Esparza

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

30 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

499-500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970117-2

7 January 2021

Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970117-2

7 January 2021

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970117-2

7 January 2021

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970117-2

7 January 2021

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970117-2

7 January 2021

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970117-2

7 January 2021

Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970117-2

7 January 2021

Immunological memory ≠ protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970117-2

7 January 2021

10.1016/S1473-3099(12)70117-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference